Anika Therapeutics (ANIK)
(Delayed Data from NSDQ)
$25.50 USD
+0.14 (0.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $25.47 -0.03 (-0.12%) 4:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 0.30 |
EPS Last Quarter | 0.17 |
Last EPS Surprise | -26.09% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.58 |
Next Year | 0.87 |
EPS (TTM) | -4.89 |
P/E (F1) | 43.72 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 42.17M | 45.44M | 170.05M | 179.42M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 42.17M | 45.44M | 170.05M | 179.42M |
Low Estimate | 42.17M | 45.44M | 170.05M | 179.42M |
Year ago Sales | 41.47M | 42.97M | 166.66M | 170.05M |
Year over Year Growth Est. | 1.69% | 5.75% | 2.03% | 5.51% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30 | 0.44 | 0.58 | 0.87 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | 0.30 | 0.44 | 1.00 | 1.32 |
High Estimate | 0.30 | 0.44 | 1.00 | 1.32 |
Low Estimate | 0.30 | 0.44 | 0.16 | 0.42 |
Year ago EPS | -0.45 | -4.30 | -5.64 | 0.58 |
Year over Year Growth Est. | 166.67% | 110.23% | 110.28% | 50.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.30 | 0.44 | 0.58 | 0.87 |
7 Days Ago | 0.30 | 0.44 | 0.58 | 0.87 |
30 Days Ago | 0.30 | 0.44 | 0.66 | 0.92 |
60 Days Ago | 0.34 | 0.43 | 0.70 | 0.92 |
90 Days Ago | 0.34 | 0.43 | 0.70 | 0.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.30 | 0.44 | 0.16 | 0.42 |
Zacks Consensus Estimate | 0.30 | 0.44 | 0.58 | 0.87 |
Earnings ESP | 0.00% | 0.00% | -72.41% | -51.72% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.17 | -0.31 | -4.30 | -0.45 | NA |
Estimate | 0.23 | -0.19 | -0.26 | -0.33 | NA |
Difference | -0.06 | -0.12 | -4.04 | -0.12 | -1.09 |
Surprise | -26.09% | -63.16% | -1,553.85% | -36.36% | -419.87% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more